Shares of Chr. Hansen Holding A/S (OTCMKTS:CHYHY – Get Free Report) have received an average recommendation of “Hold” from the eight brokerages that are covering the stock, MarketBeat reports. Seven research analysts have rated the stock with a hold rating and one has given a strong buy rating to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $486.67.
Separately, DNB Markets downgraded Chr. Hansen Holding A/S from a “buy” rating to a “hold” rating in a research report on Thursday.
View Our Latest Analysis on Chr. Hansen Holding A/S
Chr. Hansen Holding A/S Stock Performance
Chr. Hansen Holding A/S Company Profile
Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. The company operates through Food Cultures & Enzymes, and Health & Nutrition segments.
Recommended Stories
- Five stocks we like better than Chr. Hansen Holding A/S
- Upcoming IPO Stock Lockup Period, Explained
- MarketBeat Week in Review – 8/7 – 8/11
- What Does Downgrade Mean in Investing?
- 3 Retailers To Watch Closely Next Week
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Investing in Coffee: 3 Great Strategies to Consider
Receive News & Ratings for Chr. Hansen Holding A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chr. Hansen Holding A/S and related companies with MarketBeat.com's FREE daily email newsletter.